Stakeholders from ASCO and the Association of American Cancer Institutes (AACI) came together last year to develop the ASCO-AACI Best Practices in Cancer Clinical Trials Initiative, led by 2015–2016 ASCO President Julie M. Vose, MD, MBA, FASCO. The goal of the initiative is to promote practical solutions to meeting existing regulatory and administrative requirements on research.
Dr. Julie M. Vose
“Existing requirements are inefficient and costly,” Dr. Vose said. “We want to make sure we can get safe drugs to our patients. Improving the efficiency of clinical research is key moving forward.”
The initiative is composed of four parts:
- Survey: A measurable way to assess administrative and/or regulatory burdens associated with conducting and managing clinical trials.
- Workshop: A gathering of a large group of stakeholders focused on reaching consensus around best
practices in complying with and
interpreting existing requirements
- Workshop Proceedings: A manuscript that summarizes the discussion and recommendations from the workshop that will be published in Journal of Clinical Oncology.
- Dissemination: Project findings will be highlighted at the ASCO Annual Meeting, and practical resources and toolkits will be developed to aid in implementing best practices identified by the working group.
The survey, which was open from November 1–15, asked respondents:
- What aspects of launching a clinical trial are burdensome?
- How would you reduce or resolve these burdens?
- Are you fully aware of tools and products that can help you overcome these burdens?
- How often do you use these tools or products?
Results of the survey and the solutions generated at the workshop for improving clinical trial efficiency will be presented during the Annual Meeting. For more information on developments in clinical trials, visit the Clinical Trials page on asco.org.